Status:

COMPLETED

Survivorship Post-HCT Optimization Program

Lead Sponsor:

Duke University

Conditions:

Hematologic Malignancy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The purpose of this project is to investigate the effects of 12 weeks of high-intensity interval training (HIIT) and resistance training on several domains of health including physical function, cogni...

Eligibility Criteria

Inclusion

  • Patient
  • ≥18 years old
  • English speaking
  • Within 90 ± 30 days post allogenic HCT
  • Caregiver
  • ≥18 years old
  • English speaking
  • Providing post-discharge care for the patient who has undergone HCT
  • Patient and Caregiver

Exclusion

  • Have an absolute contraindication to exercise including a recent acute cardiac event (\<6 months), unstable angina, uncontrolled dysthymias causing symptoms or hemodynamic compromise, symptomatic aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary embolus, acute myocarditis or pericarditis, suspects or known dissecting aneurism, or coronary artery disease.
  • In addition to these absolute contraindications, the patient and caregiver will complete cardiopulmonary exercise testing (CPET) where the heart rate and heart rhythm will be monitored via a 12-lead ECG before, during, and after the test. The results from the CPET will be reviewed by a physician before the subject is cleared to participate in the HIIT and resistance training program. If the participant is not cleared by the physician following the CPET, then the patient and his or her caregiver will not be eligible to participate in the study.

Key Trial Info

Start Date :

December 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 23 2025

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT05238376

Start Date

December 2 2022

End Date

March 23 2025

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke Adult Blood and Marrow Transplant Clinic

Durham, North Carolina, United States, 27705